Plasma Citrulline as a Biomarker for Early Diagnosis of Necrotizing Enterocolitis in Preterm Infants

Abstract

Objective Citrulline synthesized by healthy enterocytes and decreases with injury. This work aimed to study plasma citrulline concentrations (CITs) as a biomarker to differentiate among infants presenting with early nonspecific signs and symptoms of necrotizing enterocolitis (NEC) with those who will develop NEC. Further to study the correlation between posttreatment CIT with time to full feeds (TTFF) and length of stay (LOS).

Study Design This is a prospective study which included infants < 32 weeks gestational age (GA) with 9 infants each in Group 1 (stage 2/3 NEC), Group 2 (with stage 1 NEC-like presentation), and Group 3 (healthy GA-matched infants). CIT was measured in Groups 1 and 2 within 24 hours of presentation and again in Group 1 after treatment.

Results The three groups were similar in clinical characteristics. Median CIT (µmol/L) in Group 1 (15.4 [interquartile range, IQR: 7.3–18.0]) was lower than Group 2 (22.2 [IQR: 18.3–27.3], p = 0.02) and Group 3 (24.9 [IQR: 19.8–31.9], p = 0.009). Posttreatment CIT in Group 1 did not correlate with TTFF (r = 0.15; p = 0.69) and LOS (r =  − 0.33; p = 0.38).

Conclusion CIT was lower in infants with NEC as compared with healthy controls and those infants with nonspecific signs of NEC. CIT after treatment does not correlate with TTFF and LOS.

Key Points

• Citrulline is produced by enterocytes.

• It is decreased in infants with necrotizing enterocolitis early in disease.

• It can be used as a biomarker for early diagnosis of necrotizing enterocolitis.

Keywords

citrulline - necrotizing enterocolitis - preterm - biomarker - case–control

^* Other members of Maimonides Medical Group are Alok Bhutada, MD, Michele Dyan, MD, Anju Gupta-Modak, MD, Panayot Filipov, MD, Tania Mangones, MD, and Melissa Tsai, MD.

Publikationsverlauf

Eingereicht: 24. März 2020

Angenommen: 14. Mai 2020

Artikel online veröffentlicht:
30. Juni 2020

• References

• 1 Battersby C, Santhalingam T, Costeloe K, Modi N. Incidence of neonatal necrotising enterocolitis in high-income countries: a systematic review. Arch Dis Child Fetal Neonatal Ed 2018; 103 (02) F182-F189
• 2 Stoll BJ, Hansen NI, Bell EF. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 2015; 314 (10) 1039-1051
• 3 Ganapathy V, Hay JW, Kim JH. Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med 2012; 7 (01) 29-37
• 4 Prasad M, Miller M, Bhutada A, Rastogi S. Citrulline: is it ready for primetime. its uses and limitations in neonatal medicine. J Neonatal Biol 2014; 3: 147 . doi:10.4172/2167-0897.1000147
• 5 Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol 1981; 241 (06) E473-E480
• 6 Wu G, Bazer FW, Davis TA. et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 37 (01) 153-168
• 7 Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119 (06) 1496-1505
• 8 Bailly-Botuha C, Colomb V, Thioulouse E. et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res 2009; 65 (05) 559-563
• 9 Rhoads JM, Plunkett E, Galanko J. et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 2005; 146 (04) 542-547
• 10 Papadia C, Sherwood RA, Kalantzis C. et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol 2007; 102 (07) 1474-1482
• 11 Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003; 124 (05) 1210-1219
• 12 Woo HK, Kim E, Jung YH. et al. Reduced early dried blood spot citrulline concentrations in perterm infants with meconium obstruction of prematurity. Early Hum Dev 2015; 91 (12) 777-781
• 13 Becker RM, Wu G, Galanko JA. et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 2000; 137 (06) 785-793
• 14 Ioannou HP, Diamanti E, Piretzi K, Drossou-Agakidou V, Augoustides-Savvopoulou P. Plasma citrulline concentrations in preterm infants with necrotizing enterocolitis. Early Hum Dev 2012; 88 (07) 563-566
• 15 Celik IH, Demirel G, Canpolat FE, Dilmen U. Reduced plasma citrulline concentrations in low birth weight infants with necrotizing enterocolitis. J Clin Lab Anal 2013; 27 (04) 328-332
• 16 Bell MJ, Ternberg JL, Feigin RD. et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187 (01) 1-7
• 17 Demacker PNM, Beijers AM, Donnelly JP, Blijlevens NMA, vanden Ouweland JMW. Plasma citrulline measurements using UPLC tandem mass-spectrometry to determine small intestinal enterocyte pathology. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877: 387-392
• 18 Stultz JS, Tillman EM, Helms RA. Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition. Nutr Clin Pract 2011; 26 (06) 681-687
• 19 Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?. Intensive Care Med 2011; 37 (06) 911-917
• 20 Babu S, Prasad M, Miller M. et al. Use of serum citrulline concentrations from routine newborn screen as a biomarker for necrotizing enterocolitis. Pediatr Surg Int 2019; 35 (06) 715-722
• 21 Englund A, Rogvi RA, Melgaard L, Greisen G. Citrulline concentration in routinely collected neonatal dried blood spots cannot be used to predict necrotising enterocolitis. Acta Paediatr 2014; 103 (11) 1143-1147
• 22 Goossens L, Bouvry M, Vanhaesebrouck P, Wuyts B, Van Maele G, Robberecht E. Citrulline levels in a paediatric age group: does measurement on dried blood spots have additional value?. Clin Chim Acta 2011; 412 (7-8): 661-664
• 23 Hickey M, Georgieff M, Ramel S. Neurodevelopmental outcomes following necrotizing enterocolitis. Semin Fetal Neonatal Med 2018; 23 (06) 426-432
• 24 Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. The citrulline generation test: proposal for a new enterocyte function test. Aliment Pharmacol Ther 2008; 27 (12) 1300-1310